For patients with non-dialysis CKD who estimated glomerular filtration rate (eGFR) > 25 ml/min/1.73 m2, alpha-glucosidase inhibitors (such as acarbose), sulfonylurea (such as glipizide) and insulin are alternative drugs for treatment of T2DM instead of metformin; for patient with dialysis, both sulfonylurea (such as glipizide, still can be used with caution) and insulin could be the main drugs with DPP-IV inhibitors for blood glucose control because other anti-hyperglycemic agents are contraindicated or relatively contraindicated in dialysis patients. The gene discussed is INS; the disease is type 2 diabetes mellitus.